WKL Wolters Kluwer NV

Wolters Kluwer Announces ProVation Order Sets Bidirectional Integration with Market-Leading EHR Platforms

The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, today announced development and delivery of ProVation® Order Sets bidirectional integration with the two market-leading electronic health record (EHR) platforms. These new integrations allow users to easily transfer order sets and their component elements into ProVation Order Sets for collaborative web-based review, authoring, editing, updating and approval, then back to the EHR system for production use.

“Our customers were clear that bidirectional integration with EHR systems is critical now that their needs have shifted from order set creation to order set maintenance and updating. In response, we developed advanced integration that sets a new standard among order set solutions,” said David A. Del Toro, President and CEO of Clinical Software Solutions at Wolters Kluwer. “Our powerful integration enables clients to take advantage of the robust governance, collaboration and audit features available in ProVation Order Sets. We continue to assess the market to develop and deliver the features and functionality expected from a market leader.”

ProVation Order Sets customers were instrumental in helping develop this new bidirectional EHR integration, informing development priorities and assisting in real-world testing of the integration. For example, Trinity Health in Minot, ND served as one of the advisors and beta sites for the integration with Cerner.

“Bidirectional integration with Cerner Millennium really extends the value of both ProVation Order Sets and the EHR,” said Jillane Boser, Clinical Informatics Nursing Lead at Trinity Health. “It gives us a downtime database of usable order sets that reflect the actual production content, and an efficient workflow to track and validate PowerPlans when they are new and when they are due for review. The order sets are accurate, they translate very well between the systems, and will assist us in providing the best possible care to our patients.”

A vital component of a healthcare organization’s quality improvement strategy, ProVation Order Sets is driven by clinical content management tools and powered by the trusted content of UpToDate® decision support. ProVation Order Sets streamlines cumbersome governance processes and helps providers adopt evidence-based medicine at the point of care, speeding compliance with quality measures driving reimbursement.

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

EN
16/11/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wolters Kluwer NV

 PRESS RELEASE

Share Buyback Transaction Details February 27 – March 4, 2026

Share Buyback Transaction Details February 27 – March 4, 2026 PRESS RELEASE                                         Share Buyback Transaction Details February 27 – March 4, 2026 Alphen aan den Rijn – March 5, 2026 - Wolters Kluwer (Euronext: WKL), a global leader in professional information, software solutions, and services, today reports that it has repurchased 80,106 of its own ordinary shares in the period from February 27, 2026, up to and including March 4, 2026, for €5.5 million and at an average share price of €68.11. Included is a block trade of 61,336 ordinary shares for €4.0 mill...

Guy Sips ... (+10)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Lynn Hautekeete
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List Update March 2026: Removing Aedifica – Adding Pr...

The tariff war between US and China has eased, but with the Iran conflict and an erratic Trump, uncertainty will continue into 2027. Energy prices have gone ballistic, with gas prices doubling in Europe and has hit the cyclical stocks hard. The highly anticipated AI productivity gains also will have to transpire sooner or later or a US market correction becomes unavoidable. While the macro-economic impact has been limited so far, a prolonged uncertain situation will result in economic damage. We...

 PRESS RELEASE

Wolters Kluwer recognized as one of America’s Best Large Employers for...

Wolters Kluwer recognized as one of America’s Best Large Employers for the sixth consecutive year PRESS RELEASE Wolters Kluwer recognized as one of America’s Best Large Employers for the sixth consecutive year Recognition highlights Wolters Kluwer’s strength in top talent and engineering capabilities critical to delivering AI‑powered solutions for customers Alphen aan den Rijn — March 3, 2026 — , global leader in professional information solutions, software, and services, has once again been named among , marking the sixth consecutive year the company has earned a place on the prestigiou...

Wolters Kluwers: 2 directors

Three Directors at Wolters Kluwers bought/sold after exercising options/maiden bought 5,521 shares at between 64.120EUR and 64.790EUR. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary ...

 PRESS RELEASE

Stacey Caywood has officially assumed the role of CEO at Wolters Kluwe...

Stacey Caywood has officially assumed the role of CEO at Wolters Kluwer PRESS RELEASE Stacey Caywood has officially assumed the role of CEO at Wolters Kluwer New CEO prioritizes AI investment, partnerships, and go-to-market Alphen aan den Rijn — February 27, 2026 — , a global leader in information solutions, software and services, announced that has officially assumed the role of Chief Executive Officer, succeeding Nancy McKinstry. Caywood brings a strong track record of transforming and growing businesses at Wolters Kluwer through investment in innovation, portfolio management, and c...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch